Can I get it?
Not for this use. Zepbound has no EU authorisation for it, so it cannot be prescribed or dispensed here for that purpose.
Why buying it online is riskyZepbound · San Cristóbal de La LagunaPrescription only
Online medical consultation for Zepbound in San Cristóbal de La Laguna.
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid in any pharmacy in Spain. Consultation €25/month, refunded if the doctor decides it is not safe to prescribe.
- Once-weekly pen
- Dual GIP/GLP-1 receptor action
- Doctor-supervised, step-wise escalation
Start consultationStart consultation · €25/month
Full refund if a review is not approved · Medication, if prescribed, is dispensed and paid for separately at a pharmacy.
IN PLAIN TERMS
What Zepbound is, and how to get treatment
Tirzepatide is a medicine given as an injection under the skin once a week. It acts on two natural gut-hormone signals at once, GLP-1 and GIP, which together lower appetite and slow how fast food leaves the stomach, so people usually eat less. In the EU it is sold as Mounjaro. It was first authorised in September 2022 for type 2 diabetes, and its licence was extended on 11 December 2023 to cover weight management alongside a reduced-calorie diet and more physical activity.
Zepbound has no EU marketing authorisation for this use. It may be an approved medicine for something else, or approved in another country — but not something a doctor here can prescribe for this.
Learn more about peptides at Peptidepedia.
What can I take instead?
Our doctors review every Weight loss option and recommend what fits your history and goals.
See all Weight loss optionsWhat do the studies show?
Every trial behind Zepbound is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Can I get Zepbound in San Cristóbal de La Laguna?
Yes. People in San Cristóbal de La Laguna, Spain, can request an online doctor consultation about Zepbound with Hi-Doctor. A licensed EU doctor reviews the case and issues a prescription only when clinically appropriate. If approved, the electronic prescription arrives as a QR code that can be dispensed directly in Spain.
Availability
Zepbound is available to residents of Spain through the online consultation. A prescription follows only if the doctor approves it.
- Country
- Spain
- Language of service
- Spanish and English
- Prescription turnaround
- In less than 4 hours on average, only if the doctor approves
- Honoured locally
- QR electronic prescription, dispensed directly in Spain
How the EU prescription works where you are: In Spain, an approved prescription arrives electronically with a QR code for direct dispensing.
VERIFIED EVIDENCE
Zepbound: evidence and regulatory guide.
WHAT IT IS
How it works
It switches on two gut-hormone receptors at the same time, GIP and GLP-1, which together reduce appetite and slow how quickly the stomach empties.
- GIP
- GLP-1
DEVELOPMENT STAGE
Not marketed in the EU
Trial register1 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| SURMOUNT-1NCT04184622 | Adults with a BMI of 30 kg/m² or more, or 27 kg/m² or more with at least one weight-related complication, without type 2 diabetes; all received diet and exercise counselling | 2,539 | Read out | 2022-07-21 |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Peer-reviewed
Jastreboff AM, Aronne LJ, Ahmad NN, et al; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038 (PMID 35658024)| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| 5 mg once weekly | −15.0% | 72 |
| 10 mg once weekly | −19.5% | 72 |
| 15 mg once weekly | −20.9% | 72 |
| Placebo | −3.1% | 72 |
Figures are the treatment-regimen estimand at week 72; people with type 2 diabetes were excluded, everyone also received diet and exercise counselling, and the trial did not follow weight after treatment stopped.
Sources
Last reviewed 2026-07-27
NAMED SAFETY SIGNALS
What has been reported with Zepbound.
Nausea
In SURMOUNT-1, reported by 24.6% (5 mg), 33.3% (10 mg) and 31.0% (15 mg) versus 9.5% on placebo.
Diarrhoea
In SURMOUNT-1, reported by 18.7% (5 mg), 21.2% (10 mg) and 23.0% (15 mg) versus 7.3% on placebo.
Constipation
In SURMOUNT-1, reported by 16.8% (5 mg), 17.1% (10 mg) and 11.7% (15 mg) versus 5.8% on placebo.
Vomiting
In SURMOUNT-1, reported by 8.3% (5 mg), 10.7% (10 mg) and 12.2% (15 mg) versus 1.7% on placebo.
Hair thinning
Alopecia was reported by 5.1% (5 mg), 4.9% (10 mg) and 5.7% (15 mg) versus 0.9% on placebo in SURMOUNT-1.
Acute pancreatitis
Independently confirmed in 3 people on tirzepatide and 1 on placebo across the SURMOUNT-1 safety dataset reviewed by the EMA.
Stopping treatment because of side effects
4.3% (5 mg), 7.1% (10 mg) and 6.2% (15 mg) stopped treatment because of side effects versus 2.6% on placebo.
FormPre-filled injection pen
FrequencyOnce a week
ResultsGradual, over months
StatusPrescription only
About
What is Zepbound?
Active ingredient: Tirzepatide · Dosages: 2.5 – 15 mg / week
Tirzepatide is a dual receptor agonist — it acts on the GLP-1 and GIP gut-hormone receptors at the same time. In clinical trials this translates into larger average weight loss than mono-agonist GLP-1s in adults with obesity.
It's a chronic treatment for as long as it's beneficial and safe: the doctor reviews your response every 3 months and decides with you whether to continue, adjust or stop. Discontinuation is gradual and paired with a maintenance plan.
How it works in the body
By activating two receptors at once, tirzepatide reinforces satiety signals, slows stomach emptying and helps regulate the insulin response — so you tend to eat less without counting every calorie.
How it helps
Three ways it supports weight loss.
Dual action
Works on two gut-hormone receptors (GLP-1 + GIP), not just one.
Reinforces satiety
Hunger eases and fullness lasts longer after smaller meals.
Reviewed quarterly
Your doctor reassesses response and tolerance every 3 months before renewing.
What to expect
A step-wise, supervised escalation.
The dose is escalated step-wise (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg) every 4 weeks while the body adapts. Your doctor sets your exact schedule.
- Weeks 1–4 · 2.5 mg starting dose
- From week 5 · Step up every 4 weeks as tolerated
- Month 4+ · Personalised maintenance dose
- Ongoing · Quarterly medical reviews
Typical escalation
- Weeks 1–42.5 mg / week
- Step-ups (every 4 weeks)5 → 7.5 → 10 → 12.5 mg
- Maximum dose15 mg / week
Your schedule is personal
These are typical steps only. Your doctor adjusts the plan to how you respond and tolerate it — and you can message them at any point.
Safety first
Safety, in full.
Zepbound is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.
Adults with obesity (BMI ≥30) or with overweight (BMI ≥27) plus at least one weight-related condition.
- Once-weekly self-injection in the thigh, abdomen or upper arm.
- Dose is escalated step-wise (2.5 mg → 5 → 7.5 → 10 → 12.5 → 15 mg) every 4 weeks while the body adapts.
- Combined with diet and physical activity — tirzepatide complements, not replaces, lifestyle change.
Who should not take it
- Personal or family history of medullary thyroid carcinoma or MEN 2.
- Pregnancy, planned pregnancy in the next 2 months, or breastfeeding.
- History of pancreatitis.
- Type 1 diabetes or diabetic ketoacidosis.
- Severe gastroparesis.
When to seek urgent care
For severe, sudden or unexpected symptoms, call your local emergency number or go to the nearest emergency department. Then let your doctor know through your account chat.
PRICING
You only pay if treatment is approved.
€25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth. One-off consultations are €35 for sexual health and €40 for dermatology.
Weight loss
ONGOING PLAN
€25/month
Billed €25 every 28 days · cancel anytime
28-day treatment cycle
For ongoing treatment and doctor-reviewed renewals.
Renewals reviewed by your doctor
Start consultation
Full refund if a review is not approved
WHAT'S INCLUDED
- First consultation included
- Renewals reviewed by your doctor
- Ongoing care with your doctor
- Cancel anytime
Full refund if a review is not approved
If a review is not approved, we refund that period's €25 fee and cancel the plan.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
HOW THE DOCTOR DECIDES
A licensed doctor reviews your case, not an algorithm
An EU-licensed doctor reads your questionnaire and answers in less than 2 hours on average.
If the doctor decides it is not safe to prescribe, the consultation fee is refunded in full.
Follow-up happens in the private chat inside your account, under GDPR. No WhatsApp, no SMS.
OTHER WEIGHT LOSS TREATMENTS
Explore related treatments.
Find out if it's right for you
See if Zepbound is appropriate for you.
Answer a few questions and a licensed EU doctor reviews your case in less than 2 hours on average. Refunded in full if it's not right for you.